20,000 Shares in Agilent Technologies, Inc. $A Purchased by Rhenman & Partners Asset Management AB

Rhenman & Partners Asset Management AB acquired a new position in shares of Agilent Technologies, Inc. (NYSE:A) in the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 20,000 shares of the medical research company’s stock, valued at approximately $2,721,000.

A number of other hedge funds and other institutional investors also recently bought and sold shares of the company. Wealthspire Advisors LLC boosted its holdings in Agilent Technologies by 36.6% during the 4th quarter. Wealthspire Advisors LLC now owns 2,569 shares of the medical research company’s stock valued at $350,000 after acquiring an additional 689 shares during the period. Advisors Asset Management Inc. boosted its holdings in Agilent Technologies by 58.3% during the 4th quarter. Advisors Asset Management Inc. now owns 13,928 shares of the medical research company’s stock valued at $1,895,000 after acquiring an additional 5,129 shares during the period. Federation des caisses Desjardins du Quebec boosted its holdings in Agilent Technologies by 2.5% during the 4th quarter. Federation des caisses Desjardins du Quebec now owns 21,839 shares of the medical research company’s stock valued at $2,972,000 after acquiring an additional 540 shares during the period. HRT Financial LP purchased a new position in Agilent Technologies during the 4th quarter valued at about $32,847,000. Finally, DRW Securities LLC purchased a new position in Agilent Technologies during the 4th quarter valued at about $278,000.

Agilent Technologies Stock Performance

Shares of A opened at $129.76 on Friday. The stock has a 50-day simple moving average of $120.24 and a 200-day simple moving average of $127.86. The company has a debt-to-equity ratio of 0.43, a quick ratio of 1.62 and a current ratio of 2.10. The stock has a market capitalization of $36.65 billion, a PE ratio of 26.06, a PEG ratio of 2.31 and a beta of 1.26. Agilent Technologies, Inc. has a 1 year low of $108.35 and a 1 year high of $160.27.

Agilent Technologies (NYSE:A) last announced its quarterly earnings data on Wednesday, May 27th. The medical research company reported $1.49 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.41 by $0.08. The business had revenue of $1.84 billion during the quarter, compared to analysts’ expectations of $1.80 billion. Agilent Technologies had a return on equity of 24.33% and a net margin of 19.55%.The business’s quarterly revenue was up 10.0% compared to the same quarter last year. During the same quarter last year, the business posted $1.31 EPS. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. On average, analysts predict that Agilent Technologies, Inc. will post 6 earnings per share for the current fiscal year.

Agilent Technologies Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 22nd. Stockholders of record on Tuesday, June 30th will be paid a $0.255 dividend. This represents a $1.02 annualized dividend and a dividend yield of 0.8%. The ex-dividend date is Tuesday, June 30th. Agilent Technologies’s dividend payout ratio (DPR) is presently 20.48%.

Analysts Set New Price Targets

A number of equities analysts recently commented on the company. Robert W. Baird raised their target price on Agilent Technologies from $155.00 to $156.00 and gave the company an “outperform” rating in a report on Tuesday, May 26th. Weiss Ratings upgraded Agilent Technologies from a “hold (c-)” rating to a “hold (c)” rating in a report on Tuesday, June 2nd. Morgan Stanley lowered their target price on Agilent Technologies from $180.00 to $160.00 and set an “overweight” rating for the company in a report on Tuesday, March 3rd. Wolfe Research restated a “hold” rating on shares of Agilent Technologies in a report on Tuesday, June 2nd. Finally, Wall Street Zen upgraded Agilent Technologies from a “hold” rating to a “buy” rating in a report on Saturday, May 30th. One research analyst has rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and three have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $160.93.

Agilent Technologies Company Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.